NEW YORK (TIP): The U.S.-Indian relationship is fast building a strategic partnership  and the two sides working together with  regional groupings as highlighted by the Indian Prime Minister and the US President including ASEAN and Quad members, to promote shared interests in the Indo-Pacific region and beyond; developing a trade and investment partnership that increases prosperity for working families in both countries; finishing the fight against the COVID-19 pandemic and other health challenges; galvanizing global efforts to scale up climate action;  strengthening democratic values and institutions in support of our respective peoples; and enhancing people-to-people ties that have made both countries stronger, Mr. H.S. Panaser said in a press note to The Indian Panorama.

President Joe Biden has created history by appointing about 60 Indian Americans to key positions in his administration. The latest is the senate approval of The White House Office of National Drug Control Policy, Dr. Rahul Gupta. It was a great pleasure joining him during his first visit to India after his taking over the position.

As President of Global Indian Trade and Cultural Council, USA, (GITCC) Mr. Panaser visited India with Advisors on Board  Mr. Suresh Khanna,  Chairman of M/s. Stabicon Life Sciences Pvt. Ltd and Member of the Board of Millipore Pvt. Ltd. India, a JV company of Millipore Corporation USA. Mr. Anand. Krishnamurthy,  CEO of Coolsoft LLC, USA, Gen. Dilawar Singh. The group visited, Delhi, Bangalore, Ahmedabad, and Chandigarh respectively. They had an opportunity to meet bureaucrats overseeing healthcare,  IT and irrigation in the  states of Haryana and Punjab.They  had meeting and discussions with Industry leaders and Indian bureaucrats on Pharmaceutical and Medical devices manufacturing emphasizing on joint ventures, mergers both for generic and prescription products and API. The visiting  team also discussed about new software and usage of AI and ML in the healthcare sector.

Mr. Panaser has a strong network of Angel Investors, Venture Capitalists and other Financial Consultants. India has very experienced and qualified pool of people who can assist in Formulation Product Development, Compiling dossiers for product registration for markets worldwide, API DMF, SOP Writing, Clinical Data Management, Validation protocols etc. at a very competitive cost. These costs will be affordable by many small and medium scale companies, thereby making them competitive commercially., Mr. Panaser’s press note said.

Mr. Panaser also talked to Dr. Rahul Gupta about starting a government private partnership for spearheading campaigns on Drug awareness in border states to fight widespread drug menace in India under corporate social responsibility following the US model. The visiting team had a fruitful meeting with Mr. Ravi Nath Sinha, Director, MSME Business Forum of India  and General Dilawar Singh, Director General Skill Development, Member Consultative Committee for New Educational Policy · Member, National Committee on Management of Youth.